Tenon Medical, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
TNON$1.74-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Operations and Comprehensive Loss
Condensed Statements of Operations and Comprehensive Loss (Unaudited)
(In thousands, except per share data)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue | $1,379 | $726 |
| Cost of revenue | 434 | 403 |
| Gross Profit | 945 | 323 |
| Operating Expenses | ||
| Research and development | 662 | 691 |
| Sales and marketing | 1,858 | 1,647 |
| General and administrative | 1,705 | 1,662 |
| Total Operating Expenses | 4,225 | 4,000 |
| Loss from Operations | (3,280) | (3,677) |
| Other (Expense) Income, net | ||
| Gain on investments | 25 | 61 |
| Interest expense | (176) | — |
| Other expense | (45) | — |
| Total Other (Expense) Income, net | (196) | 61 |
| Net Loss | $(3,476) | $(3,616) |
| Net Loss Per Share of Common Stock | ||
| Basic and diluted | $(0.31) | $(1.01) |
| Weighted Average Shares of Common Stock Outstanding | ||
| Basic and diluted | 11,268 | 3,597 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.